What is UHS's 12-month stock price target?

Universal Health Services Inc. (UHS) carries a 12-month consensus base price target of $183.9 (+1.8% from $180.65), with a bull-case target of $258.65 and a bear-case floor of $143.44.

Stock Ratings / Health Care / UHS / forecast

ENSG (68) EHC (77) PACS (73) THC (74) ⌘ Pro Terminal →

Universal Health Services Inc. (UHS) 12-Month Stock Forecast & Price Target Cone

Q: Is UHS stock a Buy, Hold, or Sell right now?

Roarable's 5-Pillar RQD Quant Engine rates UHS C (Hold — HOLD) with an RQD Confidence score of 62/100.

$180.65 +2.61% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $181.16

Universal Health Services Inc. (UHS) carries a Roarable Rating of C (Hold) with 62/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.

ROARABLE C • HOLD / WATCH Cap $10.38B

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on UHS Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is UHS stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-03, Universal Health Services Inc. (NYSE: UHS) is rated C (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 62/100 at a spot price of $180.65 (+2.61% 1D, market cap $10.38B). Pillar breakdown: Fundamental Cash Engine 10/20, Institutional 13F & Options Flow 9/20, SEC Balance-Sheet Forensics 15/20, FRED Macro Regime Fit 10/20, and Executive Insider Alignment 18/20. Across 1015 tracked Health Care issuers, UHS ranks #145 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does UHS compare to ENSG and EHC in the Health Care sector?

▼

Within the Health Care sector (Hospital/Nursing Management), UHS carries a Roarable C (62/100 RQD), trailing P/E of 7.0x, gross margin of —, and ROIC of 14.1%. By comparison, ENSG (The Ensign Group Inc.) holds a C+ grade (68/100 RQD, P/E 31.6x, ROIC 18.0%, cap $10.59B) and EHC (Encompass Health Corporation) posts a B+ grade (77/100 RQD, P/E 22.9x, ROIC 13.8%, cap $13.41B). Among the 5-stock peer group, UHS leads on earnings multiple (7.0x) while THC leads on capital efficiency (27.6% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for UHS?

▼

Per UHS's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000352915), Universal Health Services Inc. generated $17.36B in revenue (+9.7% YoY), $1.49B in net income, and $849.2M in free cash flow against $15.53B in total assets and $4.00B in total debt. Key quantitative strengths: Company leadership has skin in the game with net positive insider conviction. Primary risk factors monitored: Sensitive to high interest rates and tighter Federal Reserve market liquidity. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $181.16 (+0.28%)🧬 Cannibal Buyback (-2.92% YoY Shares)⚙️ Cash Engine: 10/20 (D) • 4.9% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record: Scores of 62/100 (C) historically posted market-perform odds over rolling 90-day windows (+0.7% avg 90D alpha vs SPY • 54.3% hit rate — wait for RQD ≥ 70 breakout).

Audit Bucket Track Record →

RQD QUANT TACHOMETERHOLD / WATCH • C

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw C · Rk C

Each axis scored 0–20

12M PRICE TARGET CONE+1.8% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for UHS)Realized 20D OHLCV Swing Band: ±6.6%

Deterministic 5-Pillar Attribution (62/100 Composite)

🔍 WHY UHS SCORES 62/100 (C) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Insider Conviction & Share Dilution+18/20 pts (29% of score)

SEC Form 4 / 13F Thermometer: 86% Net Buy • Cannibal Buyback (-2.92% YoY Shares)

▲ #2 Bullish Driver: SEC 10-K Forensic Risk+15/20 pts (24% of score)

Altman Z-Score 3.11 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 9/9

▼ #1 Drag / Risk Factor: Whale & Options Positioning9/20 pts (-11 pt drag)

Put hedging (50% put share) caps near-term gamma upside (-11 pts vs max)

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade B$185.89-1.6% Next Q

Q2 (-2Q)

Grade B-$182.87-5.8% Next Q

Q3 (-1Q)

Grade C+$172.18+4.9% Next Q

Current

Grade C$180.65+0.7% Hist 90D α

Trajectory: B (70) → C (62)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the UHS Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 62/100 (C) score, UHS faces multiple-compression risk if 7.0x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Sensitive to high interest rates and tighter Federal Reserve market liquidity.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Cannibal Buyback (-2.92% YoY Shares) — any gross margin slip below 49.5% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($177.28) or 200D SMA ($176.61) invalidates the momentum regime and cuts Target Base ($183.90) toward Bear Floor ($143.44).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $UHS• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “UHS Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 62%NO 38%Trade / Inspect Odds →

INTERACTIVE 12-MONTH POSITION SIMULATOR

Drag to Test Your UHS Position Size: $10,000

Shares at $180.65: 55.4 sh

$1,000$10,000$25,000$50,000$100,000

12M Bear Case FloorTarget $143.44

$7,940

$-2,060 (-20.6%)

12M Consensus BaseTarget $183.90

$10,180

+$180 (+1.8%)

12M Bull Case BreakoutTarget $258.65

$14,318

+$4,318 (+43.2%)

Wall Street Analyst Breakdown & Historical Accuracy Audit (28 Desks)

Street Historical Accuracy: 64/100

● Strong Buy / Buy: 17● Hold: 9● Sell: 2

Wall Street Firm	Stance	12M Target	1Y Accuracy	Track Grade
Morgan StanleyInstitutional Equity Desk	HOLD	$191	74%	A
Goldman SachsSector Coverage Lead	BUY	$243	69%	B
JP MorganUS Large-Cap Research	HOLD	$164	58%	C

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Quantitative Research Desk

Scheduled RQD Strong Buys & Whale Accumulation Briefing (UHS Tape Review)

✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
✓Forensic Red-Light accounting & dilution traps to review on your watchlist
✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

UHS // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +8.78%▲ ASCENDING CHANNEL

2026-11-03O $176.6H $180.7L $176.1C $180.7VOL 582.2K

RES: $194.5SUP: $169.5SMA50: $177.3SMA200: $176.6

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

UHS Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 UHS Butterfly Map → + Track UHS →

Share Count & Dilution Monitor

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle

-8.0%/yr Implied 5Y Growth

vs. +9.7% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on UHS today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for UHS. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for UHS today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (UHS)

Health Care Rank #145 of 1015 ⚔️ ENSG vs UHS Full Matrix →

1. Head-to-Head Health Care Peer Comparison (UHS vs. ENSG, EHC, PACS, THC)

Industry: Hospital/Nursing Management (14 Tracked Issuers)

Across 1015 tracked Health Care securities in the Roarable RQD universe, Universal Health Services Inc. (UHS) ranks #145 by composite RQD confidence (62/100, grade C) and #105 by equity capitalization ($10.38B). Within this direct 5-issuer industry benchmark cohort, UHS leads on earnings valuation at 7.0x trailing P/E, while THC leads on capital efficiency and profitability with 27.6% ROIC and — gross margin. EHC currently holds the highest overall quantitative score in the immediate peer group at 77/100 (B+) compared with UHS at 62/100 (C).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
UHS ACTIVE Universal Health Services Inc.	C	62/100	7.0x	—	14.1%	+2.61%	$10.38B	Benchmark Subject
ENSG The Ensign Group Inc.	C+	68/100	31.6x	20.1%	18.0%	-1.35%	$10.59B	/ensg-vs-uhs →
EHC Encompass Health Corporation	B+	77/100	22.9x	—	13.8%	+0.95%	$13.41B	/ehc-vs-uhs →
PACS PACS Group Inc.	B	73/100	41.1x	—	24.6%	-4.66%	$7.57B	/pacs-vs-uhs →
THC Tenet Healthcare Corporation	B	74/100	9.2x	—	27.6%	-1.60%	$21.75B	/thc-vs-uhs →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0000352915 ↗

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Universal Health Services Inc. (UHS) reported GAAP revenue of $17.36B (+9.7% vs. FY2024 revenue of $15.83B , and +21.6% cumulative change since FY2023) , GAAP net income of $1.49B, operating cash flow of $1.86B, and free cash flow of $849.2M (-24.4% YoY). On the balance sheet, UHS closed FY2025 with $15.53B in total assets against $4.00B in total debt (Altman Z-Score: 3.11, Piotroski F-Score: 9/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$17.36B	$1.49B	$1.86B	$849.2M	$15.53B	$4.00B
FY2024 (FY)	2024-12-31	$15.83B	$1.14B	$2.07B	$1.12B	$14.47B	$4.46B
FY2023 (FY)	2023-12-31	$14.28B	$717.8M	$1.27B	$625.1M	$17.14B	$4.01B

3. UHS Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is UHS stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does UHS compare to ENSG and EHC in the Health Care sector?

What are the biggest fundamental strengths and SEC risk factors for UHS?

Where is UHS trading relative to its 50-day, 200-day, and 52-week technical levels?

UHS last traded at $180.65 (+2.61% on volume of 910,957 shares), positioning the stock +1.90% above its 50-day simple moving average ($177.28) and +2.29% above its 200-day simple moving average ($176.61). Across its 52-week range of $140.08 to $246.33, UHS sits at the 38.2% percentile with a 14-day RSI of 45.7 (NEUTRAL RANGE) and an implied next-earnings move of ±6.6% ($168.73 to $192.57).

Direct Sub-Reports: UHS RQD Cockpit UHS 12M Forecast UHS Earnings & Move UHS Dividends & DRIP UHS Insiders & 13F UHS Whale Options UHS Profit Sankey UHS News & Why

ROARABLE RATING BRIEF • RQD 62/100 (C) ✓ SEC XBRL & RQD VERIFIED

UHS — Universal Health Services Inc.: What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit

Updated: 2025-12-31

1. Roarable Rating Brief: What This Means to a Prospective Investor

Universal Health Services Inc. (UHS) earns a live Roarable RQD composite score of 62/100, corresponding to a C letter grade (Roarable Hold) at a spot price of $180.65 (+2.61% 1D, market capitalization $10.38B).

Fundamental Cash Engine (10/20): Anchored by return on invested capital (ROIC) of 14.1%, gross margin of —, operating margin of 11.5%, and free cash flow yield of 8.16%.
Whale 13F & Options Flow (9/20) + Insider Conviction (18/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
Macro Regime Fit (10/20) + Forensic Balance Sheet (15/20): Incorporates a 1.04x equity beta, Altman Z-Score of 3.11, Piotroski F-Score of 9/9, and Debt/Equity of 0.55x.

2. Business Model, Unit Margins & SEC Financial Trajectory

Universal Health Services Inc. (UHS) is a NYSE-listed issuer in the Health Care sector, operating in the Hospital/Nursing Management industry. The source profile identifies it as a hospital and nursing management operator. Revenue for FY 2025 was $17.36B. — for detailed customer segmentation or revenue model breakdown.

In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), Universal Health Services Inc. (UHS) reported $17.36B in annual revenue (up from $15.83B in FY2024, +9.7% YoY) and $1.49B in GAAP net income. Over the multi-year SEC filing window from FY2023 ($14.28B revenue, $717.8M net income) through FY2025, UHS scaled operating cash flow to $1.86B and free cash flow to $849.2M, backed by $15.53B in total assets against $4.00B in total debt.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

🐂 Primary Bull Case (C • RQD 62/100): Company leadership has skin in the game with net positive insider conviction. Clean SEC annual filing review with no major hidden accounting time-bombs. With Fundamental Cash Engine at 10/20 and Institutional Whale Flow at 9/20, sustained execution supports upside toward the upper end of the $140.08 – $246.33 52-week range.
🐻 Primary Bear Case & Valuation Risk: Sensitive to high interest rates and tighter Federal Reserve market liquidity. Investors must weigh 7.0x trailing P/E and 5.0x EV/EBITDA against 11.5% operating margins and a 1.04x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

Upstream and downstream dependencies cannot be mapped from the source data. Sector membership (Health Care) and industry (Hospital/Nursing Management) are the only available context.

Key Question #1: Can UHS sustain or expand its 11.5% operating margin and 14.1% ROIC against Hospital/Nursing Management peers over the next 4 quarters?
Key Question #2: Following FY2025 revenue of $17.36B and free cash flow of $849.2M, how will capital allocation balance growth reinvestment against $4.00B in total debt?
Key Question #3: How sensitive is UHS's 6.5x forward P/E multiple to Health Care capital spending cycles and macro interest-rate shifts (Beta 1.04x)?

UHS Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Universal Health Services Inc. (UHS) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to UHS Debate Forum (3) ↓

🔴 RISK WATCH Yahoo Finance • 22h ago

Universal Health Services (UHS) Stock Sees Modest Fair Value Cut After Mixed Analyst Views

Yahoo Finance report covering Universal Health Services Inc. (UHS) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🔴 RISK WATCH Seeking Alpha • 1d ago

Universal Health: Bears Have Taken It Too Far - 134% Upside (NYSE:UHS)

Seeking Alpha report covering Universal Health Services Inc. (UHS) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Yahoo Finance • 1d ago

Earnings Preview: What to Expect From Universal Health Services’ Report

Yahoo Finance report covering Universal Health Services Inc. (UHS) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🔴 RISK WATCH TradingView • 1d ago

UHS Misses Q3 Earnings Estimates Despite Higher Patient Volumes

TradingView report covering Universal Health Services Inc. (UHS) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE GuruFocus • 1d ago

Universal Health Services Inc Reports Q3 2026 Earnings: EPS of $

GuruFocus report covering Universal Health Services Inc. (UHS) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Yahoo Finance • 1d ago

Universal Health Services earnings: what to look for from UHS

Yahoo Finance report covering Universal Health Services Inc. (UHS) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE TradingView • 1d ago

Universal Health Services’s Q3 earnings call: our top 5 analyst questions

TradingView report covering Universal Health Services Inc. (UHS) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Yahoo Finance • 1d ago

Universal Health Services, Inc. (UHS) Stock Forecasts

Yahoo Finance report covering Universal Health Services Inc. (UHS) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

UHS Bull vs. Bear Conversation Board — What's Your Call at $180.65?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON UHS 🐻 33% BEARISH CONVICTION

TA TapeReader_Pro RQD DEBATE OPENER • Price Action & Volume Trader 🐂 BULLISH 🎯 Target: $218.30 (+24.0%)

📌 Pinned Debate

Low valuation (forward P/E 6.5, EV/EBITDA 5) alongside 18/20 insider conviction and a Piotroski F-Score of 9/9 point to upside if earni

Here is why I am bullish on UHS here at $176.05: Low valuation (forward P/E 6.5, EV/EBITDA 5) alongside 18/20 insider conviction and a Piotroski F-Score of 9/9 point to upside if earnings hold.. Compare UHS's 11.5% operating margin and 14.1% ROIC against the rest of Hospital/Nursing Management. As long as cash conversion holds up, dips toward $167.25 are getting bought.

VolSurface_Trader 🐂 BULL

Both sides have a point here — UHS's 15/20 balance sheet score keeps downside contained, so the real swing factor next earnings call is backlog and FCF conversion.

SH ShortSeller_Dan RQD DEBATE OPENER • Forensic Short Bias 🐻 BEARISH 🎯 Target: $142.60 (-19.0%)

Spot @ $176.05

Q3 earnings reportedly missed estimates and the RQD rating scores macro fit and institutional flow only 10/20 each, leaving the thesis

Careful chasing UHS at $176.05. Q3 earnings reportedly missed estimates and the RQD rating scores macro fit and institutional flow only 10/20 each, leaving the thesis dependent on unresolved risks.. Gross margin is 0.0%, but operating margin is 11.5%, which shows SG&A and reinvestment are eating into bottom-line EPS. Target $142.60 on multiple compression.